INJEKSTIONSNADELEINHEIT

European patent · EP2320973 · In force

Register entry

Publication number
EP2320973
Application number
EP09761641
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 2, 2009
Published
May 18, 2011
Granted
Sep 26, 2018
Protection ends at the latest
Jun 1, 2029
Next annual fee due
Jun 30, 2027
IPC classes
A61M 5/24 (2006.01)
A61M 5/34 (2006.01)
A61M 5/32 (2006.01)
Priority
US 60191 P 10.06.2008
SE 0850110 01.12.2008
PCT application
PCT/EP2009/056750 02.06.2009
PCT publication
WO2009/150078 17.12.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. Mar 21, 2019

    Transferred

    Owner
    SHL Group AB, P.O. Box 1240, (Augustendalsvägen 7), 131 28 Nacka Strand, Sweden → SHL Medical AG, Gubelstrasse 22, PO Box 7710, 6302 Zug

    Published in Swissreg on 21.03.2019

  7. Sep 26, 2018

    Granted

    Published in Swissreg on 26.09.2018

Parties

Holder

SHL Medical AG

Gubelstrasse 22 PO Box 7710, 6302 Zug

Inventor

GIAMBATTISTA, Lucio

East Hannover, NJ 07936-1809, US

BENDEK, Antonio

Vernon, NJ 07462, US

DE SALVO, David

LAke Hiawatha, NJ 07034, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.